Expertise in
14
conditions

Dr. Shernan G. Holtan

Hematology
U Of M Health Clinics And Surgery Center Inc.
909 Fulton St SE, 
Minneapolis, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
20 Years of Experience
Expertise in
14
conditions
U Of M Health Clinics And Surgery Center Inc.
909 Fulton St SE, 
Minneapolis, MN 

Overview

Shernan Holtan is a Hematologist practicing medicine in Minneapolis, Minnesota. She has been practicing medicine for over 20 years.

Dr. Holtan is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 181 peer reviewed articles and participating in 6 clinical trials. Dr. Holtan is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in MN

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

U of M Health Clinics and Surgery Center Inc.
909 Fulton St SE, Minneapolis, MN 55455
Other Locations
Office
720 Washington Ave SE, Minneapolis, MN 55414

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
Enrollment Status: Recruiting
Publish Date: June 25, 2026
Intervention Type: Biological
Study Phase: Phase 2
Neoadjuvant Therapy for Patients With High Risk Stage III Melanoma: A Pilot Clinical Trial
Neoadjuvant Therapy for Patients With High Risk Stage III Melanoma: A Pilot Clinical Trial
Enrollment Status: Completed
Publish Date: May 04, 2026
Intervention Type: Drug, Biological
Study Drugs: Atezolizumab, Cobimetinib, Vemurafenib
Study Phase: Phase 2
MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG
MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Drug, Biological
Study Drugs: Fludarabine, Busulfan, Anti-Thymocyte Globulin, Thiotepa, Rituximab, Alemtuzumab, N-Acetylcysteine, Celecoxib, Vitamin E, Alpha Lipoic Acid
Study Phase: Phase 2
INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation
INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Other
Study Phase: Phase 3
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Biological
Study Phase: Phase 1
A Phase I Study of Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease (SR-aGVHD) or Treatment-refractory Acute Graft-versus-host Disease (TR-aGVHD)
A Phase I Study of Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease (SR-aGVHD) or Treatment-refractory Acute Graft-versus-host Disease (TR-aGVHD)
Enrollment Status: Completed
Publish Date: January 19, 2023
Intervention Type: Biological
Study Drug: Neihulizumab (AbGn-168H)
Study Phase: Phase 1
View 5 Less Clinical Trials

181 Total Publications

Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases.
Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases.
Journal: Cureus
Published: July 14, 2026
Similar Doctors
Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Fairview Pharmacy Services LLC

516 Delaware St SE, 
Minneapolis, MN 
 (0.3 miles away)
612-626-2663
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Weisdorf is a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Weisdorf is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Graft. Dr. Weisdorf is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

M Health Fairview Center For Bleeding And Clotting Disorders

2512 South 7th Street, Suite 105, 
Minneapolis, MN 
 (0.6 miles away)
612-273-5005
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Reding is a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Reding is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Hemophilia B, Splenectomy, and Bone Marrow Transplant. Dr. Reding is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

U Of M Health Clinics And Surgery Center Inc.

909 Fulton St SE, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English
See accepted insurances

Erica Warlick is a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Warlick is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Shernan G. Holtan

How do I make an appointment with Dr. Shernan G. Holtan?

You can book an appointment with Dr. Shernan G. Holtan by calling their office at 612-676-4200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shernan G. Holtan a top-rated expert for Graft Versus Host Disease (GvHD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shernan G. Holtan is classified as an Elite expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shernan G. Holtan specialize in?

While Dr. Shernan G. Holtan is a Hematology, they have specific expertise in Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), and Chronic Graft Versus Host Disease (cGvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Shernan G. Holtan participate in research or clinical trials?

Yes. Dr. Shernan G. Holtan has published 181 articles and abstracts on conditions like Graft Versus Host Disease (GvHD). You can view a list of Dr. Shernan G. Holtan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shernan G. Holtan accept my insurance?

Dr. Shernan G. Holtan accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 612-676-4200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Holtan's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile